Alexander Gee

Acting for Galapagos NV on the sale of its Jyseleca (filgotinib) business, including the commercial, medical affairs and development activities for Jyseleca, to Alfasigma for EUR 50 million upfront, milestone payments of up to EUR 120 million and royalties on European sales.

Acting for GSK on the separation of its biopharma and consumer healthcare businesses into its consumer healthcare joint venture with Pfizer, and the operational aspects of the subsequent listing of the joint venture company, Haleon plc, on the London Stock Exchange.

Acting for Coats plc on its acquisition of Texon, the global shoe components business, from Navis Capital Partners for USD 297 million, and of Rhenoflex, the global footwear solutions business.

Acting for eMed on its acquisition of the majority of Babylon Health's UK business, which provides technology-driven preventative healthcare services, alongside other traditional healthcare activities.

Acting for Vertiv, a provider of critical infrastructure and continuity solutions, on its USD 2 billion acquisition of E&I Engineering.

Acting for Donaldson Company on its EUR 136 million acquisition of Univercells Technologies, a global producer of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing.

Acting for IVI RMA, a KKR portfolio company, on its EUR 500 million acquisition of Eugin Group, Fresenius’ fertility and reproduction-services business, in consortium bid with GED Capital.

Acting for Mondelēz International on the acquisition of a majority interest in Grenade, a UK-based nutrition group.

Acting for Embracer Group on its USD 137.2 million acquisition of Flying Wild Hog, through its subsidiary Koch Media, and its acquisition of Silent Games, through its wholly owned subsidiary Amplifier Game Invest AB.

Acting for GSK on the divestment of its rabies and tick-borne encephalitis vaccines to Bavarian Nordic for an upfront payment of approximately EUR 301 million and milestone payments of up to EUR 955 million.